DK487382A - Fjernelse af immunkompleks og udvikling af tumorspecifikt antistof med immobiliseret protein a-perfusion og laegemiddelinfusion efter perfusion - Google Patents

Fjernelse af immunkompleks og udvikling af tumorspecifikt antistof med immobiliseret protein a-perfusion og laegemiddelinfusion efter perfusion Download PDF

Info

Publication number
DK487382A
DK487382A DK487382A DK487382A DK487382A DK 487382 A DK487382 A DK 487382A DK 487382 A DK487382 A DK 487382A DK 487382 A DK487382 A DK 487382A DK 487382 A DK487382 A DK 487382A
Authority
DK
Denmark
Prior art keywords
perfusion
removal
development
specific antibody
immune complex
Prior art date
Application number
DK487382A
Other languages
Danish (da)
English (en)
Inventor
David Stephen Terman
Original Assignee
Baylor College Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College Medicine filed Critical Baylor College Medicine
Publication of DK487382A publication Critical patent/DK487382A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • External Artificial Organs (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK487382A 1981-11-06 1982-11-03 Fjernelse af immunkompleks og udvikling af tumorspecifikt antistof med immobiliseret protein a-perfusion og laegemiddelinfusion efter perfusion DK487382A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US32332681A 1981-11-06 1981-11-06

Publications (1)

Publication Number Publication Date
DK487382A true DK487382A (da) 1983-05-07

Family

ID=23258717

Family Applications (1)

Application Number Title Priority Date Filing Date
DK487382A DK487382A (da) 1981-11-06 1982-11-03 Fjernelse af immunkompleks og udvikling af tumorspecifikt antistof med immobiliseret protein a-perfusion og laegemiddelinfusion efter perfusion

Country Status (10)

Country Link
EP (1) EP0079221A3 (de)
JP (1) JPS5886168A (de)
KR (1) KR840002244A (de)
AU (1) AU570911B2 (de)
CA (1) CA1197460A (de)
DK (1) DK487382A (de)
ES (3) ES517174A0 (de)
FI (1) FI823761A7 (de)
IL (1) IL66959A0 (de)
NO (1) NO823672L (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120821A (ja) * 1983-12-05 1985-06-28 Asahi Chem Ind Co Ltd 悪性腫瘍治療用白血球刺激材および刺激方法
DE3422435A1 (de) * 1984-06-16 1986-01-16 B. Braun Melsungen Ag, 3508 Melsungen Verfahren und vorrichtung zur selektiven abtrennung pathologischer und/oder toxischer spezies aus blut oder blutplasma unter verwendung von filterkerzen
US4704366A (en) * 1984-06-22 1987-11-03 Bio-Rad Laboratories, Inc. Process for binding IgG to protein A
US4614513A (en) * 1984-08-13 1986-09-30 Fred Hutchinson Cancer Research Center Method and apparatus for treatment to remove immunoreactive substances from blood
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
SE8801426D0 (sv) * 1988-04-15 1988-04-15 Ulf Rothman Forfarande och medel for blodbehandling

Also Published As

Publication number Publication date
ES8501984A1 (es) 1984-12-16
FI823761A0 (fi) 1982-11-03
ES523790A0 (es) 1984-12-16
FI823761L (fi) 1983-05-07
EP0079221A3 (de) 1986-01-22
EP0079221A2 (de) 1983-05-18
KR840002244A (ko) 1984-06-25
ES8503202A1 (es) 1984-12-16
ES523791A0 (es) 1984-12-16
NO823672L (no) 1983-05-09
JPS5886168A (ja) 1983-05-23
IL66959A0 (en) 1983-02-23
FI823761A7 (fi) 1983-05-07
AU570911B2 (en) 1988-03-31
AU8918982A (en) 1985-02-07
CA1197460A (en) 1985-12-03
ES8402506A1 (es) 1983-12-01
ES517174A0 (es) 1983-12-01

Similar Documents

Publication Publication Date Title
DK338587A (da) Modulsamling af antistofgener, antistoffer fremstillet derved samt anvendelse deraf
FI840642A7 (fi) Menetelmä ja laite veren virtauksen kuvaamiseksi ydinmagneettiresonanssin avulla.
NO169947C (no) Fremgangsmaate for fremstilling av et monoklonalt antistoff til et tumorassosiert antigen
NO302176B1 (no) Fremgangsmåte for fremstilling av et monoklonalt antistoff og et antigen
FR2551918B1 (fr) Appareil pour coller un film adhesif sur un anneau de support et un objet mince
FR2513125B1 (fr) Medicament curatif du deficit immunitaire
DK98187D0 (da) Monoklonale antistoffer og antigen for human ikke-smaacellet lungecarcinoma og visse andre typer human carcinoma
DK149990D0 (da) Familie af modificerede antistoffer med hoej affinitet til cancerbehandling
DK614984D0 (da) Enolethere af oxicamer og farmaceutiske praeparater indeholdende disse
FI901791A7 (fi) Lymfosyyttien reaktivisuuden määrittäminen veressä olevien spesifistenantigeenien suhteen
DK105982A (da) Fremgangsmaade til fremstilling af vaeskeabsorberende granulat samt et vaeskeabsorberende granulat fremstillet ifoelge fremgangsmaaden
DK487382A (da) Fjernelse af immunkompleks og udvikling af tumorspecifikt antistof med immobiliseret protein a-perfusion og laegemiddelinfusion efter perfusion
DK109887D0 (da) Farmaceutisk praeparat indeholdende antistoffer
DK110781A (da) Magnetisk styret laegemiddelinfusionsystem
IT1104619B (it) Antigeni e anticorpi della teofillina
FI810007A7 (fi) Ihmisen syöpäsolujen toteaminen vasta- aineilla jotka ovat spesifisiä ihmisen syöpäsolujen tumajyväsantigeenetumajyväsantigeeneille.
DK436184A (da) Specifikke cea-familie-antigener, antistoffer specifikke dertil og deres anvendelsesmaader
DK610587D0 (da) Analysemetode og -saet for antistof til hepatitis b-kerneantigen
DK21586D0 (da) Antigener og antistoffer samt praeparater indeholdende disse
NO170691C (no) Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav
KR860005021A (ko) HBc 항원의 정재방법 및 정제된 HBc 항원을 이용한 HBc 항체의 측정방법
DK169381A (da) Fremgangsmaade til detektion af en blodgruppes antigener og m2ddel til udoevelse af fremgangsmaaden
KR890700832A (ko) 그람 음성균의 항원 결정기와 결합하는 사람 단일클론성 항체
FR2497672B1 (fr) Pied support a serum portable pour la transfusion et la perfusion sanguine
ZA828167B (en) Immune complex removal and tumor specific antibody generation by immobilized protein and a perfusion and postperfusion drug infusion

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment